|
|
|
|
|
Chairman |
|
|
|
Jürgen Langhärig, Ph.D., MBA |
Kai Lahtonen |
Miriam Frieden, MSc, Ph.D., EMBA |
|
VP, Business Development |
President&CEO |
Director, Business Development |
|
|
|
|
|
Bavarian Nordic A/S |
Biocelex Ltd |
santaris pharma |
|
Hejreskovvej 10A |
Lemminkäisenkatu 5 C, 6th floor |
Kogle Allé 6 |
|
DK-3490 Kvistgård |
FI-20520 Turku |
DK 2970 Hørsholm |
|
Denmark |
Finland |
Denmark |
|
|
|
|
|
Tel: +45 3326 8383 |
|
Tel: +45 4517 9800 |
|
Direct: +45 3328 8318 |
Direct : +358 50 689 48 |
Direct: +45 4517 9822 |
|
Cell: +45 3051 4841 |
|
Cell: +45 4058 9805 |
|
|
|
|
|
jla@bavarian-nordic.dk |
kai.lahtonen@biocelex.com |
mfr@santaris.com |
|
www.bavarian-nordic.com |
www.biocelex.com |
www.santaris.com |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasurer |
|
Markus Thor |
Ole Wiborg |
Jens Aakersoe |
|
Chief Business Officer |
Managing Partner, CEO |
Licensing Director, |
|
|
|
Corporate Strategy & Business Development
|
|
|
|
|
|
Novacia AB |
Wiborg ApS |
Novo Nordisk A/S
|
|
Lindhagensgatan 133 |
Børge Allé |
Novo Allé |
|
SE112 51 Stockholm |
2970 Hørsholm |
DK-2880 Bagsværd |
|
Sweden |
Denmark |
Denmark |
|
|
|
|
|
|
|
Tel: +45 4444 8888 |
|
Direct: +46 735 20 40 35
|
Direct +45 4587 1910 |
Direct: +45 4442 3799
|
|
|
Cell: +45 4096 8018 |
Cell: +45 3079 3799
|
|
|
|
|
|
markus.thor@inovacia.se |
ow@wiborg.com |
jeaa@novonordisk.com |
|
www.inovacia.se |
www.wiborg.com |
www.novonordisk.com |
|
|
|
|
|